The Global NASH Council in the News

The Global NASH/MASH Council (GNC) and Global Liver Council (GLC) Actively Participated in the AASLD Meeting in Washington, D.C. (November 7–11)

This year’s AASLD meeting was a highly productive and engaging event for members of the Global NASH/MASH Council (GNC) and Global Liver Council (GLC). In addition to hosting a successful joint annual GNC/GLC meeting featuring insightful presentations and discussions, members also delivered a total of 18 research presentations, including 4 oral presentations and 14 poster...Continue reading→

Global NASH/MASH Council (GNC) and Global Liver Council (GLC) Bi-annual Meeting at AASLD 2025, Washington, D.C.

Over 100 members of the Global NASH/MASH Council (GNC) and the Global Liver Council (GLC), representing leading hepatology experts from more than 30 countries worldwide, attended the 11th bi-annual GNC/GLC meeting held during AASLD 2025 in Washington, D.C. The meeting commenced with opening remarks from Professor Zobair Younossi, Chair of the GNC/GLC, who highlighted the...Continue reading→

Projected Global Clinical, Humanistic, and Economic Impact of Metabolic Dysfunction-Associated Steatohepatitis (MASH)

MASH is rapidly emerging as one of the most common causes of chronic liver disease worldwide, yet its economic impact has often been underestimated. The Global NASH/MASH Council (GNC) recently conducted an in-depth analysis of the future burden of MASH across nine countries, including the U.S., Germany, France, UK, Italy, Spain, Japan, Brazil, and Saudi...Continue reading→

International Paris Liver Meeting 2026- Save the Date

Dear Colleagues, We would like to invite you to save the date for the International Paris Liver Meeting 2026, a three-day program taking place January 19–21, 2026, covering the latest topics in hepatology, including steatotic liver disease (MASLD, MetALD, ALD), cholestatic liver diseases, viral hepatitis, hepatocellular carcinoma (HCC), and complications of cirrhosis. Join the international...Continue reading→

Global Consensus Recommendations for Metabolic Dysfunction Associated Steatotic Liver Disease and Steatohepatitis

This month’s cover of the prestigious journal Gastroenterology features a landmark study by the Global NASH/MASH Council (GNC), which developed global consensus recommendations on the burden, risk stratification, and treatment of MASLD/MASH. By systematically reviewing 61 guidance documents worldwide, the study identified 46 areas of discordance that may create uncertainty for clinicians. Through a four-round...Continue reading→

Managing MASLD Through Preventive Hepatology: Integrating Policy Reform, Public Health, and Personalized Care

The prevalence of MASLD/MASH is rising globally, highlighting the urgent need for public health policies that emphasize both prevention and personalized care. MASLD/MASH carries significant clinical, humanistic, and economic burdens worldwide. Primary prevention strategies should prioritize lifestyle interventions guided by a social nutrition agenda, alongside public health initiatives to increase awareness among healthcare practitioners and...Continue reading→

Welcoming the New Co-Chairs of the Patient Advocacy Committee of GNC/GLC

The GNC and GLC extend their heartfelt appreciation to Diane Langenbacher and Nikos Dedes for their outstanding leadership as co-chairs of the Patient Advocacy Committee over the past several years. Their dedication has been instrumental in ensuring that the patient voice remains central to all our initiatives, and we are deeply grateful for their contributions....Continue reading→